US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Dibutyl Squaric Acid

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1156-03 D-0435-2022
Class II · Moderate risk Terminated

Dibutyl Squaric Acid

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1047-03 D-0434-2022
Class II · Moderate risk Terminated

CSF Otic Insufflation Capsule

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1633-05 D-0431-2022
Class II · Moderate risk Terminated

Cantharidin PLUS

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-0970-03 D-0430-2022
Class II · Moderate risk Terminated

BLT Topical Cream

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1235-01 D-0428-2022
Class II · Moderate risk Terminated

Vancomycin HCl

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-0736-01 D-0424-2022
Class II · Moderate risk Terminated

Betadine

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1680-01 D-0423-2022
Class II · Moderate risk Terminated

Phenylephrine HCl/Tropicamide

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-0815-01 D-0420-2022
Class II · Moderate risk Terminated

Phenylephrine HCl/Lidocaine

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1118-01 D-0419-2022
Class II · Moderate risk Terminated

PHENYLephrine

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1667-01 D-0418-2022
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1652-01 D-0417-2022
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1544-10 D-0416-2022
Class II · Moderate risk Terminated

Phenylephrine HCl 0.5 mg/5mL

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1545-05 D-0415-2022
Class II · Moderate risk Terminated

Phenol

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1476-05 D-0413-2022
Class II · Moderate risk Terminated

Mvasi

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1661-13 D-0412-2022
Class II · Moderate risk Terminated

Neostigmine methylsulfate

Reason Lack of Assurance of Sterility

Edge Pharma, LLC NDC 05446-1549-05 D-0411-2022